ALEXANDRA INGRAM: Open Payments
NPI 1730843194 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,588 in 41 payments from 10 companies in 2025. Trend: 2023 $476 · 2024 $432 · 2025 $6,588
Travel & lodging: $2,628Consulting: $2,582Food & beverage: $1,333Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $3,822 |
| Medtronic, Inc. | 14 | $2,134 |
| Neurocrine BioSciences, Inc. | 3 | $183 |
| PolyNovo North America LLC | 1 | $154 |
| ACADIA Pharmaceuticals Inc | 2 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $63 |
| MDD US Operations, LLC | 3 | $54 |
| Lilly USA, LLC | 1 | $22 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| Cala Health, Inc. | 1 | $17 |
Products named: VYALEV, PERCEPT PC BRAINSENSE, INGREZZA, NOVOSORB BTM, NUPLAZID, AUSTEDO XR, Apokyn, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
